PERIOPERATION CHANGES COLON AND RECTUM MICROBIOCINOSIS WITH COLORECTAL PATIENTS
PDF (Русский)

Keywords

MICROBIOCENOSIS
MICROFLORA
DYSBIOSIS
COLON CANCER
INTESTINAL MICROBIOTA
DYSBACTERIOSIS
COLITIS
COLORECTAL CANCER

How to Cite

Zakharenko, A., Belyaev, M., Ten, O., Trushin, A., Rybalchenko, V., Dzhamilov, S., & Kursenko, R. (2019). PERIOPERATION CHANGES COLON AND RECTUM MICROBIOCINOSIS WITH COLORECTAL PATIENTS. Voprosy Onkologii, 65(4), 516–523. https://doi.org/10.37469/0507-3758-2019-65-4-516-523

Abstract

Most colorectal cancer patients prove to have dysbiosis of varying severity. Perioperative period contributes to the progression of the microbiocenosis disorders. It has been proven that a large role in the development of postoperative complications is played by the state of the colon microflora.

Materials. 211 colorectal cancer patient’s (T1-4N0-2M0) colon microflora was studied by PCR. Surgeries were performed laparoscopically. In the main group, developed diagnostic algorithm was used, in which initial colon flora was studied with dysbiosis progression risk determination by developed logistic regression model and perioperative correction of revealed disorders. Standards of dysbiosis treatment were used.

Results. 100% patients in control group proved to have dysbiosis of varying severity: 1 grade - 27,4% (n=14), 2 grade - 37,3% (n=19), 3 grade - 31,4% (n=16), 4 grade - 3,9% (n=2). Dysbiosis progression was observed in postoperative period: 1 grade - 7,8% (n=4), 2 grade - 51,0% (n=26), 3 grade - 29,4% (n=15), 4 grade - 11,8% (n=6). The same preoperative results were registered in main group. However, after perioperative correction there was 12,5% (n=6) 3 grade and no registered 4 grade patients. Long-term results were better in the main group than in the control group. Adverse events were significantly higher in the control group against the main group (15,7% (n=8) and 4,2% (n=2) respectively).

Discussion. We recommend preoperative stool analysis with PCR for colon microflora determination in order to further dysbiosis correction and treatment long-term results assessment.

https://doi.org/10.37469/0507-3758-2019-65-4-516-523
PDF (Русский)

References

Wistrom J., Ragnar Norrby S., Erling B. Myhre et al. Frequency of antibiotic-associated diarrhea in 2462 antibiotic-treated hospitalized patients a prospective study // Journal of antimicrobial chemotherapy. - 2001. - № 47. - P 43-50.

Захаренко А.А., Суворов А.Н., Шлык И.В. и др. Нарушения микробиоценоза кишечника у больных колоректальным раком и способы их коррекции // Колопроктология. - 2016. - № 2. - С. 48-56.

Bonnet M., Buc E., Sauvanet P. et al. Colonization of the human gut by E. coli and colorectal cancer risk // Clin. Cancer Res. - 2014. - Vol. 20 - P 859-867.

Ley R.E., Peterson D.A., Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine // Cell. - 2016. - № 124. - P 837-848.

Bauer M., Kuijper E., van Dissel J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI) // Clin. Microbiol. Infect. - 2009. - Vol. 15 - P 1067-1079.

Spigaglia P. Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection // Ther. Adv. Infect. Dis. - 2016. - Vol. 3. - № 1. - P 23-42.

Ханевич М.Д., Шашолин М.А., Зязин А.А. Колоректальный рак. Подготовка толстой кишки к операции. - М.: ИнтелТек, 2003.

Воронина О.В.: Коррекция дисбиоза у больных после операций на органах желудочно-кишечного тракта: дис. канд.мед. наук. ГМА им. И.И. Мечникова, Санкт-Петербург, 2009.

Sartelli M., Malangoni M.A., Abu-Zidan F.M., Griffiths E.A., di Bella S., et al. WSES guidelines for management of Clostridium difficile infection in surgical patients // World J. Emerg. Surg. - 2015. - Vol. 10. - № 1. - P 38.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2019